Simvastatin in Overcoming Chemotherapy Resistance in Patients With Relapsed or Refractory Multiple Myeloma
Status:
Withdrawn
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies how well simvastatin works in overcoming chemotherapy
resistance in patients with multiple myeloma that has come back or does not respond to
treatment. Simvastatin may stop the growth of cancer cells by blocking some of the enzymes
needed for cell growth.